Boulevard Bio
Business Services · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
New York City, New York, United StatesWebsite
www.boulevardbio.comRevenue
<$5 MillionIndustry
About Boulevard Bio
Boulevard Bio is a precision immunology company built to change the course of B cell-driven autoimmune diseases with targeted, multi-specific medicines designed to set new therapeutic standards. Boulevard is advancing a pipeline of multi-specific antibodies grounded in a deep understanding of B cell disease biology to pair the right targets and modalities to the right disease across the spectrum of B cell-driven autoimmune conditions. The company was founded by pioneers in B cell biology and was incubated by Deerfield Management with molecules developed inside Deerfield Discovery and Development (3DC), the firm’s internal therapeutics research and development engine. The company’s corporate headquarters are in New York City at Cure, an affiliate of Deerfield.Explore more
Boulevard Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Boulevard Bio
Sign Up For FreeTo access detailed company insights
Boulevard Bio is a precision immunology company built to change the course of B cell-driven autoimmune diseases with targeted, multi-specific medicines designed to set new therapeutic standards. Boulevard is advancing a pipeline of multi-specific antibodies grounded in a deep understanding of B cell disease biology to pair the right targets and mod... Read More
